A variety of novel drugs are being studied for the treatment of MM including immune-modulating drugs, proteasome inhibitors, monoclonal antibodies, HDAC inhibitors, nuclear export inhibitor and so on5. This evidence concerns the gene HDAC9 and Miyoshi myopathy.